AHF Raises Concerns About Express Scripts Lawsuit over PBM Practices

Tuesday, 17 September 2024, 20:56

AHF raises concerns over Express Scripts' lawsuit to retract a critical PBM report. This action coincides with the FTC's preparations for litigation against major PBMs, addressing anticompetitive practices that impact the prescription drug market. This article delves into the implications and context behind these significant developments in healthcare.
LivaRava_Medicine_Default.png
AHF Raises Concerns About Express Scripts Lawsuit over PBM Practices

In a significant move, AHF raises pressing concerns about the recent lawsuit filed by Express Scripts to retract a critical report on pharmacy benefit managers (PBMs). This lawsuit coincides with the FTC's readiness to take legal action against the three largest PBMs, targeting an array of anticompetitive practices that have been known to distort the prescription drug market in favor of drug middlemen.

The ramifications of such legal actions are profound, not only for stakeholders within the healthcare industry but also for patients who rely on equitable drug pricing. The timing of the lawsuit raises questions about transparency within the PBM sector and the necessity for regulatory updates to protect consumer interests.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe